ABSTRACT-Septic shock increases vascular permeability, leading to multiple organ failure including cardiac dysfunction, a major contributor to septic death. Podosome, an actin-based dynamic membrane structure, plays critical roles in extracellular matrix degradation and angiogenesis. However, whether podosome contributes to endothelial barrier dysfunction during septic shock remains unknown. In this study, we found that the endothelial hyperpermeability, stimulated by phorbol 12-myristate 13-acetate and thrombin, was accompanied by increased formation of podosome clusters at the cell periphery, indicating a positive correlation between podosome clusters and endothelial leakage. Interestingly, we observed that circulating exosomes collected from septic mice were able to stimulate podosome cluster formation in cardiac endothelial cells, together with increased permeability in vitro/in vivo and cardiac dysfunction. Mechanistically, we identified that septic exosomes contained higher levels of reactive oxygen species (ROS) than normal ones, which were effectively transported to endothelial cells (ECs). Depletion of ROS in septic exosomes significantly reduced their capacity for promoting podosome cluster formation and thereby dampened vascular leakage. Finally, we elucidated that podosome cluster-induced endothelial hyperpermeability was associated with fragmentation/depletion of zonula occludens-1 (ZO-1) at the cell periphery. Our results demonstrate that septic exosomes were enriched with high amounts of ROS, which can be transported to ECs, leading to the generation of podosome clusters in target ECs and thereby, causing ZO-1 relocation, vascular leakage, and cardiac dysfunction.
INTRODUCTION
Sepsis is initiated by an uncontrolled immune response following a local severe infection (1) . Despite recent advances in antibiotic therapy and supportive critical care, sepsis remains a leading cause of death in intensive care units (1) . Endothelial barrier disruption is well recognized to be a major complication in sepsis, as it can induce microvascular hyperpermeability, leading to cardiac dysfunction and eventually heart failure (2) . Notably, septic patients with myocardial dysfunction have a much higher mortality rate (70%) than those without cardiac abnormalities (20%) (3) . At present, most prior studies have focused on the sepsis-triggered endothelial barrier dysfunction in the lungs that results in lung edema and acute respiratory distress syndrome (ARDS) (4) . However, sepsis-caused cardiac vascular hyperpermeability and its underlying mechanisms have been less investigated.
Podosome is an actin-based cytoskeletal structure containing abundant F-actin, integrin, and actin regulators such as cortactin, Arp2/3 complex, and adhesion mediators (i.e., paxillin and vinculin) (5) . It is predominately found at the outer surface of plasma membrane in animal cells (i.e., monocytic lineage, smooth muscle cells, epithelial cells, and endothelial cells) (5) . Numerous studies have pointed out several pivotal roles of podosomes in extracellular matrix degradation, invasive cell motility, and sprouting angiogenesis (6, 7) . Particularly, a recent study by Kremerskothen et al. demonstrated that zonula occludens-1 (ZO-1), a central regulator of intercellular junctions, is involved in the formation of podosomes through relocation from cytosol and cell cortex to newly formed podosomes (8, 9) . Therefore, we speculated that podosomes might function in breaking cardiac endothelial integrity through targeting ZO-1.
Exosomes are membrane-bound nanovesicles naturally released from living cells. Prior studies had indicated that exosomes, collected from platelets of sepsis patients, contained NADPH oxidase subunits: p22 and gp91, and exhibited intrinsic reactive oxygen species (ROS) production and induces vascular cell apoptosis (10, 11) . We recently made novel findings that global blockade of exosome generation in mice could attenuate sepsis-triggered inflammatory response and thereby improve cardiac function (12) . Nonetheless, whether circulating exosomes released under septic conditions affect podosome formation in cardiac vascular cells and further lead to vascular hyperpermeability has not been investigated.
In this study, we first tested whether podosome formation stimulated by Phorbol 12-myristate 13-acetate (PMA) in mouse cardiac endothelial cells (MCECs) could affect their permeability; and the thrombin-induced endothelial barrier disruption was accompanied by the formation of podosome. Next, we examined the effects of circulating exosomes collected from septic mice on the podosome formation in MCECs and endothelial permeability. Lastly, the possible mechanisms were identified. We found that, during septic shock, circulating exosomal ROS could be transported to endothelial cells, leading to the formation of podosome clusters which, in turn, caused the fragmentation/depletion of ZO-1, a controller of endothelial adherent junctions and barrier formation.
MATERIALS AND METHODS

Animals and MCEC cell line
Male C57BL/6 mice (8-wk old) were obtained from Jackson Laboratory (Indianapolis, Ind). A mouse cardiac endothelial cell line (MCEC), initially developed in Dr. Weksler's laboratory, was purchased from CELLutions Biosystems Inc. (Burlington, ON, Canada) (13) . Details about animal care and cell culture conditions are described in Supplemental methods, http:// links.lww.com/SHK/A607.
Isolation and characterizations of circulating exosomes
Circulating exosomes were collected at various time points from mice subjected to LPS injection or cecal ligation and puncture (CLP) surgery (septic exosomes). The CLP surgeries were conducted according to previous descriptions by other authors (14) (15) (16) . Circulating exosomes isolated from PBStreated or sham-operated mice were used as controls (nonseptic exosomes). Details are described in Supplemental methods, http://links.lww.com/SHK/ A607. The size and quantity of exosomes were determined by NanoSight NS300 (Malvern Instruments Ltd) as reported (17) . Data for each sample were collected for 60 s and analyzed using NanoSight NTA 3.1 software. All samples were measured in triplicates. Purified exosomes were labeled with SYTO RNA Select green fluorescent stain (Molecular Probes) following the manufacturer's instructions. MCECs were stained with Wheat Germ Agglutinin, Texas Red-X Conjugate (Molecular Probes) at 0.5 h postadministration of labeled exosomes.
In vitro endothelial permeability assay
MCECs (8 Â 10 4 cells/well) were seeded onto 12-well Transwell with 0.4-mm pore-size culture inserts (Corning Life Sciences, Lowell, Mass) and cultured for 2 to 3 days to form a monolayer. MCECs were starved with 0.5% FBS or exosome free FBS overnight before experiments. Experimental treatments with PMA (Sigma) (80 or 160 ng/mL), thrombin (Sigma) (5 U/mL), Mn (III) tetrakis (4-benzoic acid) porphyrin Chloride (MnTBPA, Merck Millipore) (40 mM) (a scavenger of ROS), exosomes (1.2 Â 10 10 particles/ mL) or relative vehicles were added to the upper compartment in order according to different experimental requirements. Endothelial permeability assay was conducted following a protocol described by Monaghan-Benson and Wittchen (18) . Details are described in Supplemental methods, http:// links.lww.com/SHK/A607.
Western blot analysis
Total protein was extracted from exosomes or PMA-treated endothelial cells with procedures described previously (16) . Equal amounts of protein were subjected to SDS-PAGE and gel electrophoresis as described in detail elsewhere (19) . The following antibodies were used: rabbit anti-CD63 (1:500, Santa Cruz), rabbit anti-ZO-1 (1:500, Invitrogen), rabbit anti-cortactin (1:1,000; Abcam); rabbit anti-paxillin (1:2,000; Abcam), and rabbit anti-GAPDH (1:1,000; Cell Signaling) used as an internal control.
Immunofluorescence microscopy
Immunofluorescence staining was performed by standard methods and is described in Supplemental methods, http://links.lww.com/SHK/A607. Cells were imaged with a confocal LSM 710 (Carl Zeiss Microimaging, Jena, Germany). Images were recorded with ZEN (Black) and analyzed with ImageJ software (Wayne Rasband, National Institutes of Health, Bethesda, Md). Quantitation of cells showing podosome cluster on cell edge was assessed in three independent experiments. At least 250 cells were counted in each experiment.
To obtain live images of endothelial cells, MCECs were transiently cotransfected with Cortactin-pmCherryC1 (a gift from Christien Merrifield, Addgene plasmid # 27676) (20) and mEGFP-Lifeact-7 (a gift from Michael Davidson, Addgene plasmid # 54610) with Lipofectamine 3000 (Invitrogen) according to the manufacturer's instructions. MCECs were imaged with Nikon A1R LUN-V Inverted TIRF Microscope at 100 Â /1.5 NA oil objective lense.
Measurement of ROS and lactate dehydrogenase (LDH) release assay
The ROS levels in exosomes or MCECs were measured using ROS-Glo H 2 O 2 Assay kit (G8820, Promega) according to the manufacturer's instructions. The luminescence was measured with a Tecan Microplate Reader (Tecan, Durham, NC). Background of baseline obtained from the absorption of PBS or medium was subtracted. The ROS levels in heart tissues were determined by using an oxidation-sensitive fluorescent probe, CM-H2DCFDA (Invitrogen) according to the manufacturer's instructions and procedures previously described (21) . The ROS level was measured by the fluorescence intensity in each well at an excitation wavelength of 495 nm and an emission wavelength of 530 nm.
Cell culture medium were subjected to LDH release assay with an in vitro Toxicology Assay Kit (Sigma, TOX7) following the manufacturer's instructions. The values were expressed in units per milliliter (U/mL).
In vivo measurements of cardiac vascular permeability and cardiac function
Cardiac vascular permeability was assessed by using Evans blue dye (EBD) leakage index as a marker according to the method described by CastanaresZapatero et al. (22) . Cardiac function was assessed in vivo using transthoracic echocardiography (iE33 Ultrasound System, Phillips) with a 40-MHz probe (19) . For additional details, see Supplemental methods, http://links.lww.com/ SHK/A607.
Statistics
Data were expressed as means AE SDs of the means. Significance was determined by Student t test and one-way or two-way analysis of variance where appropriate to determine the differences within groups. Statistical significance was considered when P value was <0.05.
RESULTS
PMA and thrombin both promote the generation of podosome clusters and the increase of MCECs permeability Podosomes are usually organized as two different structures (individual podosomes or podosome clusters) in arterial, venous, and microvascular ECs (7) . Both structures are rarely presented in cultured ECs, but can be formed through PMA induction (23) . To explore the possible correlation between the podosome formation and vascular permeability, mouse cardiac endothelial cells (MCECs) were treated with PMA. We observed that most vehicle-treated ECs displayed thin stress fibers, polymerized Factin along the cell cortex and concentrated cortactin at perinuclear sites (Fig. 1A , Supplementary video 1, http://links. lww.com/SHK/A608). However, in PMA-treated ECs, cortactin relocated from the perinuclear region to the cell periphery where it colocalized with F-actin to form podosomes or podosome clusters (Fig. 1A , Supplementary video 2, http://links.lww.com/ SHK/A609). In addition, the PMA-induced podosome clusters were further confirmed by double immunofluorescence staining of F-actin and paxillin (Supplemental Fig. S1 , http://links. lww.com/SHK/A607). Furthermore, the percentage of podosome cluster-containing MCECs was significantly increased in the PMA-treated group (34.0 AE 5.2%) compared with that in the control group (9.8 AE 4.4%) (Fig. 1B) . Consistently, the protein levels of cortactin and paxillin, two markers of podosome formation, were significantly increased in MCECs after PMA treatment according to our western blot analysis (Fig. 1 , C and D). In parallel, MCECs were seeded on Transwell permeable membrane, a model of barrier function in vitro, and treated with PMA (80 or 160 ng/mL) or PBS vehicle. Following treatment, EC permeability was monitored by determining values of transendothelial electrical resistance (TEER). Electrophysiological measurements showed that there were no significant changes in the TEER values for vehicle-treated MCECs over 1.5-h incubation period (Fig. 1H ). However, under PMA treatment, the resistance of monolayers was decreased by around 30% at 0.5 h posttreatment (hpt), and further decreased (55.6%, PMA 80 ng/mL; 74.6%, PMA 160 ng/mL) at 1 hpt (P < 0.001) (Fig. 1H ). In addition, the PMA-triggered disturbance on the monolayer integrity was further verified by fluorescein isothiocyanate (FITC)-dextran flux assay (Fig. 1I) .
On the contrary, thrombin is well known to induce endothelial cell monolayer permeability in vitro and in vivo via reorganization of cell-to-cell junctions (24, 25) . However, whether thrombin can promote the generation of podosome clusters in ECs remains unknown. To this end, we treated MCECs with thrombin (5 U/mL) for 30 min, followed by coimmunostaining for F-actin and cortactin. As presented in Figure 1A , thrombin promoted the generation of podosome clusters at the boundary of endothelial cells similar to PMA treatment, and the percentage podosome clusters presented in MCECs was significantly raised by almost 3-fold (31.7 AE 6.3%), compared with that in vehicle controls (12.2 AE 2.9%) (Fig. 1E ). In addition, both protein levels of cortactin and paxillin were markedly upregulated in MCECs under thrombin stimulation, similar to the PMA treatment group (Fig. 1,  F and G) . Meanwhile, EC monolayer permeability was elevated by thrombin treatment, evidenced by significant reductions (21.8%, 0.5 hpt and 33.8%, 1 hpt) in TEER values versus vehicle controls (Fig. 1J) . Collectively, all these observations indicate that there is a positive correlation between the generation of podosome clusters and the development of hyperpermeability in MCECs.
Septic exosomes increase permeability of MCECs
To determine the functional role of circulating septic exosomes, we generated a septic mouse model by cecal ligation and puncture (CLP) surgery and a mouse model of systemic endotoxemia by intraperitoneal injection of Escherichia coli lipopolysaccharides (LPS), then isolated exosomes from such mouse serum. Before applying them into cultured MCECs, we characterized exosomes by nanoparticle tracking assay and western-blot analysis. The nanoparticle tracking assay results showed that the average size of septic and nonseptic exosomes was similar ($150 nm) (Fig. 2, A and B; Supplemental Fig. S2 , http://links.lww.com/SHK/A607). The western-blot analysis showed the presence of CD63, an exosomal marker, in both septic exosomes and nonseptic exosomes (Fig. 2C) . As shown in Figure 2D , stained exosomes (Green) were internalized into MCECs (Red).
Next, we examined whether circulating septic exosomes are capable of increasing the permeability of cardiac ECs. First, MCECs were stimulated with circulating exosomes collected at four different time points postinjection of LPS/PBS and the dynamic changes of endothelial permeability were monitored by determining the cell monolayer TEER. Intriguingly, among four different groups of septic exosomes, only exosomes collected at 3 or 6 h post-LPS injection significantly reduced TEER values, compared with PBS exosome and no exosome controls (Fig. 2E) , suggesting that the function of circulating exosomes may vary during the development of systemic endotoxemia. Septic exosomes isolated at 3 h post-LPS injection (LPS 3 h Exo) caused the greatest decrease (29%) of TEER at 3 h postincubation with MCECs (Fig. 2E) . Similarly, our FITCdextran permeability assay showed that septic exosomes isolated at 3 h post-LPS injection markedly stimulated emigrations of the FITC-dextran to the lower chamber evidenced by 2-fold increase in fluorescence signal, compared with PBS exosomes treatment and vehicle controls (Fig. 2F) . Similar findings were observed in MCECs treated with circulating exosomes isolated from mice at 3 h post-CLP surgery (Fig. 2G) . Therefore, in the subsequent experiments, we used circulating exosomes collected at 3 h post-LPS injection and post-CLP to treat MCECs.
Septic exosomes induce the formation of podosome clusters in MCECs without affecting cell viability.
Considering that there is a positive correlation between the generation of podosome clusters and development of hyperpermeability in cardiac ECs, it is highly possible that septic exosomes may also stimulate the formation of podosome clusters. Thus, experiments were conducted to determine the effect of exosomes on the podosome generation. After incubating MCECs with 1.2 Â 10 10 exosomes/mL for 1.5 h, higher numbers of podosome clusters arose at the cell periphery (Fig. 3 , A and C, Supplementary video 3, http://links.lww.com/SHK/A610), and the percentage of ECs carrying podosome clusters presented around 2-fold increases in septic exosome-stimulated groups (LPS, 20.2 AE 4.6%; CLP, 18.7 AE 3.8%), compared with that in nonseptic exosome control groups (PBS, 9.9 AE 3.0%; Sham, 11.4 AE 3.3%) (Fig. 3, B and D) . In addition, there were slight but significant elevations in protein levels of cortactin and paxillin in MCECs at 2 h postseptic exosome stimulation, compared with control groups (Fig. 3, E-H) . To determine whether septic exosomeinduced permeability is due to cytotoxicity-related cell damage, LDH release assay was performed. No significant change was observed in the amount of LDH released from different groups except for the Triton X-100 treatment control (Supplemental Fig.  S3 , http://links.lww.com/SHK/A607) (P > 0.1), suggesting that the incubation of MCECs with septic exosomes (1.2 Â 10 10 exoexosomes/mL) or PMA (80 ng/mL) for 2 h did not cause cell damage. Collectively, these results demonstrate that the generation of podosome clusters could play an important role in septic exosome-triggered cardiovascular hyperpermeability.
Septic exosomes deliver ROS to MCECs which contributes to the increase of podosome clusters and endothelial permeability
Considering that part of circulating exosomes are derived from inflammatory cells (neutrophils and macrophages) which contribute to oxidative burst and endothelial dysfunction by producing large amounts of ROS during septic shock (26), we sought to determine the ROS levels in circulating exosomes. Given that hydrogen peroxide (H 2 O 2 ) has a relatively longer half-life compared with other kinds of ROS, which can be quickly converted to H 2 O 2 within cells, the change in H 2 O 2 can reflect the general alterations in intracellular ROS levels (27) . Therefore, in the present study, we measured the levels of ROS within exosomes by using ROS-Glo H 2 O 2 Assay kit (G8820, Fig. 4A , all septic exosomes presented markedly higher luminescent signals, indicating higher ROS levels in septic exosomes than nonseptic exosomes (P < 0.01). Next, we determined whether exosomal ROS can be delivered to ECs. 1.2 Â 10 10 exosomes/mL were added to cultured ECs for 1 h (PMA treatment was used as a positive control), followed by measurement of ROS levels in ECs. Compared with control groups, luminescent signals in ECs exposed to PMA/septic exosomes were respectively increased by 2.2-fold/ 1.5-fold (Fig. 4 , B-D, P < 0.01). To verify that ROS in septic exosomes is responsible for the septic exosome-induced increases of ROS in ECs, we pretreated septic exosomes with Mn (III) tetrakis (4-benzoic acid) porphyrin Chloride, MnTBAP, (MnT) at 40 mM for 1 h to scavenge exosomal ROS before stimulation. MnTBAP (MnT), as a cell permeable scavenger of ROS , possesses SOD, and catalase-like activity, which not only converts superoxide to hyperoxide, but also catalyzes dissociation of H 2 O 2 to water (28, 29) . After 1 h stimulation with MnT-pretreated septic exosomes, no increase in luminescent signals was observed in ECs, indicating that the ROS-elevating effect of septic exosomes was abolished by MnT (Fig. 4, C and D) . Thus, these observations suggest that septic exosomes are able to increase intracellular ROS levels in ECs through transferring exosomal ROS to target cells.
To determine whether PMA-induced or exosomal ROSinduced intracellular ROS in ECs are causative for the podosome cluster assembly, MCECs were pretreated with MnT (40 mM, 1 h) before addition of PMA (80 ng/mL) or incubated with septic exosomes pretreated by MnT (40 mM, 1 h). As shown in Figure 4E , the presence of MnT in ECs attenuated PMA-induced accumulation and colocalization of cortactin and F-actin at the cell periphery. In the same vein, MnT pretreatment abolished the capability of septic exosomes in inducing podosome cluster formation (Fig. 4E) . Furthermore, our quantification results showed that, upon MnT pretreatment, the percentage of podosome cluster-containing cells was decreased by 30% in PMA-treated groups (Fig. 4F) , and the percentage in septic exosome-treated groups was reduced from 20.2 AE 4.5% to 11.0 AE 2.6% (basal level) (Fig. 4G) (P < 0.01). These results indicate that septic exosomes triggered-podosome cluster generation is ROS dependent.
As there is a positive correlation between the generation of podosome clusters and development of hyperpermeability in MCECs, we speculated that the increase of podosome clusters contributes to PMA/septic exosome-triggered hyperpermeability of MCECs. To verify this, we performed TEER and FITCdextran flux assays on MCECs which were pretreated with MnT or incubated with MnT-pretreated exosomes as mentioned above. As shown in Figure 4H , PMA treatment resulted in 62% decrease of TEER value in ECs without MnT pretreatment. However, the TEER value was only decreased by 25% in MnTpretreated ECs after PMA stimulation (Fig. 4H) . Furthermore, in the FITC-dextran flux assay, the presence of MnT in ECs prevented the reduction of permeability of EC monolayer by 68% at 1 hpt and 65% at 1.5 hpt, compared with that (100%) in the absence of MnT under PMA stimulation (Fig. 4J) . Notably, scavenging exosomal ROS by applying MnT successfully prevented septic exosome-induced drop in TEER value (Fig. 4I) . Consistently, our FITC-dextran flux assay results showed that the reduction of monolayer permeability was significantly decreased by approximately 65% in ECs exposed to MnT-pretreated septic exosomes, compared with ECs subjected to un-pretreated septic exosomes (100%) (Fig. 4K) . All together, these data suggest that septic exosomes contain high levels of ROS which can be delivered to endothelial cells, leading to activation of podosome cluster formation and thereby, vascular leakage.
Podosome clusters promote endothelial dysfunction via targeting ZO-1 at the cell periphery Zonula occludens-1 (ZO-1, 225 kDa) is regarded as a controller of endothelial adherent junctions and barrier formation (8) . Moreover, ZO-1 has been demonstrated to be involved in the formation of podosomes (9) . Therefore, we speculated that the podosome cluster promoted-EC dysfunction may be associated with ZO-1. To test this speculation, MCECs were incubated with PMA (80 ng/mL, 0.5 h) or 1.2 Â 10 10 exosome/ mL for 1.5 h, and then subjected to immunofluorescence staining with the ZO-1 antibody. Under control conditions (MCECs incubated with PBS or nonseptic exosomes), a near continuous immunofluorescent signal was observed at the cell border (Fig. 5, A-C) . In contrast, pronounced fragmentation and depletion of ZO-1 were observed at 0.5 h post-PMA stimulation (Fig. 5A) . Interestingly, the ZO-1 linear pattern was partially restored by pretreating ECs with MnT for 1 h (Fig. 5A) . Similarly, addition of septic exosomes also significantly fragmented and depleted ZO-1 but not as remarkably as PMA treatment (Fig. 5, B and C) . However, application of MnT into septic exosomes abolished the fragmentation/depletion effect of septic exosomes on ZO-1 (Fig. 5, B and C) . To determine whether this fragmentation and depletion was due to the downregulation of expression or relocation of ZO-1, MCECs were exposed to 80 ng/mL PMA for 0.5 h. Then, the protein content of ZO-1 in MCECs was determined by Western blotting. Interestingly, the protein levels of ZO-1 were unchanged after PMA stimulation, compared to control conditions (Fig. 5, D and E), suggesting that the newly formed podosome clusters may cause fragmentation/depletion of ZO-1 without affecting total expression in ECs.
Septic exosomes induce cardiovascular hyperpermeability and cardiac dysfunction in vivo
To explore whether septic exosomes are capable of inducing cardiovascular permeability and cardiac dysfunction in vivo, we determined ROS levels, expression of cortactin and paxillin, Evans blue dye (EBD) leakage and cardiac function in mice exposed to septic exosomes or nonseptic exosomes (3.6 Â 10 12 exosomes/kg). At 1 hpt, ROS levels in heart tissue were remarkably increased in septic exosome-stimulated mice, compared with nonseptic exosome-stimulated mice, indicating the important role of septic exosomes in ROS delivery (Fig. 6A) . Consistent with our in vitro results, western blotting analysis showed upregulation of cortactin and paxillin in hearts of mice exposed to LPS Exo (P < 0.05) (Fig. 6, B and C) , suggesting that LPS Exo injection may promote podosome cluster formation in cardiac vascular endothelial cells of heart. Furthermore, the microvascular permeability experiment showed that the EBD extravasation was elevated by 1.8-fold at 3 hpt in the heart of mice exposed to septic exosomes, demonstrating a significant increase of cardiovascular permeability in relation to control groups (Fig. 6, D-F) .
Next, considering that vascular leakage is a major contributor to cardiac dysfunction in sepsis (2), we evaluated the effect of septic exosome on cardiac function. Cardiac function was assessed by echocardiography in mice injected with PBS, PBS Exo or LPS Exo. Septic exosome injection markedly increased left ventricular end systolic dimension (LVESd) (Fig. 6 , G and H), as well as decreased left ventricular ejection fraction (LVEF %) (Fig. 6I ) and left ventricular fractional shortening (FS) (data not shown), compared with nonseptic exosome injection and PBS injection controls. In addition, CLP Exo stimulation exhibited a similar effect on cardiac function as we observed above with LPS Exo treatment (data not shown).
DISCUSSION
Vascular leakage is an important hallmark of septic shock. Given that all blood vessels are lined with endothelial cells, the loss of endothelial integrity can account for the vascular leakage and tissue edema in sepsis. Therefore, it is important to understand both cellular and molecular mechanisms behind the endothelial barrier dysfunction. Such studies might lead to new therapies for sepsis. In this study, we discovered that PMA, thrombin, LPS-stimulated and septic circulating exosomes (mainly originate from macrophages, neutrophils, monocytes, and platelets) could promote the generation of podosome clusters at the EC periphery and, consequently, induce endothelial hyperpermeability. Mechanistically, we found that septic exosomes contained high amounts of ROS which can be delivered to target ECs leading to the elevation of intracellular ROS (Fig. 7) . By contrast, scavenging ROS in septic exosomes abolished the effects of septic exosomes on promoting the formation of podosome clusters and development of endothelial hyperpermeability. Furthermore, we recognized that the generation of podosome clusters could form interendothelial gaps by relocating ZO-1 at the cell periphery (Fig. 7) .
Exosomes contain many unique features like RNAs/DNAs, proteins, and lipids, and are perceived to be carriers of these cargoes to diverse locations in the body. After fusion with a recipient cell, exosomes transport their contents, such as micro-RNA (miRNA) and proteins, into the cytoplasm to perform various biological functions (30) . Over the past decade, exosomes have been extensively studied as miRNA and protein carriers in the cardiovascular disease research field (31) . However, in this study, we observed, for the first time, that circulating exosomes could transport active ROS to ECs, resulting in increased podosome clusters and vascular leakage. During septic shock, stimulated inflammatory cells, such as neutrophils and macrophages, produce large amounts of ROS which contribute in part to the host defence against bacterial spread but also play crucial roles in initiating intercellular junctional disassembly and vascular hyperpermeability (26, 32) . Notwithstanding, the mechanism of transportation of the ROS during sepsis from their site of origin to the place of action (such as ECs) has not been investigated yet. Although the plasma membrane has been assumed to be freely permeable to ROS, current evidences suggest that passive diffusion of ROS across cell membranes is limited due to poor permeability ROS across the plasma membrane (33) (34) (35) . Furthermore, the rapid release and ingress of ROS into the cell are essential for effective signal transduction processes during septic shock. In this study, we found that septic exosome carrying abundant ROS could enter MCECs within 0.5 h in vitro and induce ROS elevation within 1 h both in vitro and in vivo, indicating that exosomes possibly work as highly efficient transporters for ROS during septic shock. Our findings may establish a better insight into the nature and physical transport mechanisms of ROS into cells and reveal a novel function of exosomes during septic shock.
One important mechanism behind ROS-promoted endothelial permeability is that ROS are able to work as critical inducers of actin cytoskeleton reorganization in endothelial cells, leading to junctional opening and intercellular gap formation (26) . In addition, it has been shown that the generation of podosomes, as a result of actin cytoskeleton reorganization, is dependent on ROS (6). Furthermore, ROS-activated PKC, a small G protein Rho, Src tyrosine kinase, MLCK, ERK1/2 and p38 MAPK have been demonstrated to be crucial positive regulators of podosome assembly (6, (36) (37) (38) (39) . Therefore, we speculated that septic exosome-caused elevation of ROS in ECs can activate PKC, a small G protein Rho or Src tyrosine kinase which, in turn, promote the generation of podosome clusters. In the present study, we provide direct evidence showing that septic exosome-induced generation of podosome clusters in MCECs is dependent on the high amounts of ROS encased.
ZO-1, a central regulator of intercellular junctions and a major cytoskeletal organizer in ECs, not only regulates the overall distribution of F-actin but also interacts with tight junctions and adherent junctions to keep the endothelial integrity (8) . Recently, ZO-1 has been shown to be involved in podosome formation via binding cortactin, a key scaffold protein which controls actin assembly at the core region of podosomes (9) . Moreover, after PMA treatment, ZO-1 was observed to be rapidly relocated from the cell cortex toward newly formed podosomes in smooth muscle cells (9) . In the present study, we discovered that PMA treatment not only induced the generation of podosome clusters, but also caused ZO-1 fragmentation and deletion at the cell periphery without downregulating of total ZO-1 protein levels in MCECs. Similar results were observed in septic exosome-treated MCECs. More interestingly, in the presence of MnT, septic exosomes failed to induce the formation of podosome clusters, fragmentation/ deletion of ZO-1, and the increase of monolayer permeability in ECs. Likewise, pretreatment of MCECs with MnT dramatically attenuated the PMA-mediated effects on these three phenomena mentioned above. Collectively, our data presented in this study, for the first time, demonstrate that septic exosomes stimulate endothelial cells to assemble podosome clusters through the transferring of exosomal ROS to the target ECs, leading to relocation of ZO-1 from cell periphery to newly formed podosomes which, in turn, break the endothelial integrity (Fig. 7) .
It is important to mention here that platelet-derived exosomes from septic patients were previously reported to directly trigger EC apoptosis (10, 11) . However, whether such plateletderived exosomes can induce podosome formation in ECs and eventual hyperpermeability were not examined in the present study. The exosomes used in this study were isolated from the serum of septic mice, and these septic exosomes did not cause EC damage based on our LDH assay results. This difference may be ascribed to different amounts of exosomes, different cellular origins of exosomes, and/or different type of ECs used in these experiments. A recent study by Zhou et al. showed that exosomes derived from cancer cells can transfer miR-105 to endothelial cells and increase vascular permeability by targeting the tight junction protein ZO-1, which may support our present findings (40) . In addition, while this study focused on the role of septic exosomal ROS in the podosome formation and vascular hyperpermeability, we cannot exclude the contributions of other exosomal contents (i.e., miRNAs and cytokines).
In summary, we demonstrated that septic exosomes were enriched with high amounts of ROS, which can be transferred to ECs, leading to the generation of podosome clusters in the target ECs and thereby, causing the relocation of ZO-1 and the formation of interendothelial gaps (Fig. 7) . This study may present a new vascular redox-signaling pathway related to cardiovascular dysfunction in sepsis. It also uncovers a novel functional role of endothelial podosomes in vascular dysfunction.
